Guardian Pharmacy Services (NYSE:GRDN) Announces Quarterly Earnings Results

Guardian Pharmacy Services (NYSE:GRDN) posted its earnings results on Tuesday. The company reported ($2.00) EPS for the quarter, missing the consensus estimate of $0.19 by ($2.19), Zacks reports. The company had revenue of $314.39 million during the quarter, compared to analyst estimates of $303.21 million. Guardian Pharmacy Services updated its FY 2024 guidance to EPS.

Guardian Pharmacy Services Stock Down 1.3 %

Shares of NYSE GRDN traded down $0.27 during midday trading on Friday, hitting $20.73. 28,958 shares of the company’s stock traded hands, compared to its average volume of 155,913. Guardian Pharmacy Services has a 1 year low of $14.16 and a 1 year high of $23.05.

Analyst Upgrades and Downgrades

Several research analysts recently commented on GRDN shares. Raymond James started coverage on shares of Guardian Pharmacy Services in a research note on Monday, October 21st. They issued an “outperform” rating and a $21.00 target price on the stock. Truist Financial raised their target price on Guardian Pharmacy Services from $22.00 to $24.00 and gave the stock a “buy” rating in a research note on Friday. Finally, Stephens assumed coverage on shares of Guardian Pharmacy Services in a research report on Tuesday, October 22nd. They issued an “overweight” rating and a $21.00 target price for the company.

Insider Buying and Selling

In other news, Director Thomas J. Salentine, Jr. purchased 35,714 shares of the stock in a transaction on Friday, September 27th. The shares were acquired at an average price of $14.00 per share, with a total value of $499,996.00. Following the completion of the acquisition, the director now directly owns 35,714 shares of the company’s stock, valued at $499,996. This trade represents a ∞ increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is available through the SEC website.

Guardian Pharmacy Services Company Profile

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.